{"id":230571,"date":"2026-06-12T07:12:00","date_gmt":"2026-06-12T11:12:00","guid":{"rendered":"https:\/\/testing.news-you-need.com\/index.php\/2026\/06\/12\/novo-hit-with-cybersecurity-breach-urges-vigilance-among-trial-participants\/"},"modified":"2026-06-12T07:15:12","modified_gmt":"2026-06-12T11:15:12","slug":"novo-hit-with-cybersecurity-breach-urges-vigilance-among-trial-participants","status":"publish","type":"post","link":"https:\/\/testing.news-you-need.com\/index.php\/2026\/06\/12\/novo-hit-with-cybersecurity-breach-urges-vigilance-among-trial-participants\/","title":{"rendered":"Novo hit with cybersecurity breach, urges vigilance among trial participants"},"content":{"rendered":"

Novo hit with cybersecurity breach, urges vigilance among trial participants<\/a><\/p>\n

https:\/\/www.biospace.com\/business\/novo-hit-with-cybersecurity-breach-urges-vigilance-among-trial-participants<\/a><\/p>\n

Publish Date: 2026-06-12 07:12:00<\/a><\/p>\n

Source Domain: www.biospace.com<\/a><\/p>\n

Author: <\/a><\/p>\n

Using an unordered list, summarize the following article with between 4 and 8 key points.
\n Novo Nordisk has suffered a cybersecurity breach involving what the pharma called \u201cunauthorized access\u201d to their trial participants\u2019 personal data.The severity and breadth of the breach remain unclear, but Novo in a news release on Thursday said that only \u201ca limited amount of information related to patients participating in some of our clinical trials\u201d were affected. The pharma also assured study participants that the accessed data were \u201cnot directly linked to any patients by name or other direct identifiers.\u201dAmong the affected data include sex, year of birth, biomarkers, lifestyle factors and patient IDs, which are random letters and numbers used to identify a trial participant after they\u2019ve been anonymized.<\/p>\n

The company emphasized that the breach should not \u201cenable any third party to identify participants in our clinical trials,\u201d according to its Thursday release.Still, Novo urged trial participants to be vigilant and to report to the company if anything unusual happens \u201cthat is believed could be linked to the incident.\u201dFor its part, the Danish giant has launched an investigation of the breach, enlisting help from cybersecurity experts. The company has also \u201ctaken steps to address the situation,\u201d including temporarily deactivating certain internal systems. The pharma did not specify what these systems are, nor did it say how these interim security measures could affect patient experience.<\/p>\n

After Eli Lilly achieved the milestone approval of the weight loss pill Foundayo, Novo Nordisk launched a full-court press to defend oral Wegovy, which has been enjoying a record-breaking launch since January.<\/p>\n

April 2, 2026\u00a0\u00b7\u00a03 min read\u00a0\u00b7\u00a0<\/p>\n

The last few months have been looking up for Novo. The company has been widely perceived as having fumbled a years-long headstart in the GLP-1 game, ultimately conceding market leadership to Eli Lilly. Last year, Lilly\u2019s tirzepatide franchise, which includes Mounjaro for type 2 diabetes and Zepbound for chronic weight management, together brought in $36.51 billion worldwide. Novo\u2019s semaglutide, on the other hand\u2014which encompasses Ozempic, Wegovy and Rybelsus\u2014trailed slightly behind at $36.19 billion.Last December, Novo won the oral obesity race with the FDA\u2019s approval for the pill form of Wegovy. Lilly\u2019s Foundayo caught up just months later, however.<\/p>\n

Lilly\u2019s drug was an early favorite among analysts, whose initial assessments were buoyed by the Indianapolis pharma\u2019s thorough win in the injectables arena. But Novo has so far been beating expectations, with the Wegovy pill reaching 1 million patients in just 16 weeks on the market, bringing in around $355 million in Q1 sales. CEO Maziar Mike Doustdar, in an investor call last month, said that the oral drug is \u201coff to a record-breaking start in the U.S.\u201d<\/p>\n

Merck\u2019s Keytruda will soon lose exclusivity, just as weight-loss giants Eli Lilly and Novo Nordisk press in with their blockbuster GLP-1s.<\/p>\n

March 4, 2026\u00a0\u00b7\u00a09 min read\u00a0\u00b7\u00a0<\/p>\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

Novo hit with cybersecurity breach, urges vigilance among trial participants https:\/\/www.biospace.com\/business\/novo-hit-with-cybersecurity-breach-urges-vigilance-among-trial-participants Publish Date: 2026-06-12 07:12:00…<\/p>\n","protected":false},"author":1,"featured_media":230572,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"https:\/\/static.biospace.com\/dims4\/default\/03efa3d\/2147483647\/strip\/true\/crop\/1254x705+0+65\/resize\/1440x810!\/quality\/90\/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F02%2Fd5%2F8d9350f04a26817e4493499b1e9f%2Fistock-1373630175.jpg","fifu_image_alt":"","footnotes":""},"categories":[15],"tags":[30,24],"class_list":["post-230571","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cybersecurity","tag-breach","tag-cybersecurity"],"_links":{"self":[{"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/230571"}],"collection":[{"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/comments?post=230571"}],"version-history":[{"count":1,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/230571\/revisions"}],"predecessor-version":[{"id":230573,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/230571\/revisions\/230573"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/media\/230572"}],"wp:attachment":[{"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/media?parent=230571"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/categories?post=230571"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/tags?post=230571"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}